PRESS RELEASE published on 10/17/2023 at 13:59, 1 year 1 month ago Leifheit Aktiengesellschaft: New Chairman of the Board appointed
PRESS RELEASE published on 10/13/2023 at 14:06, 1 year 1 month ago EQS-Adhoc: Leifheit Aktiengesellschaft: Leifheit Group raises forecast for full year 2023
PRESS RELEASE published on 08/10/2023 at 07:55, 1 year 3 months ago Leifheit Aktiengesellschaft: Growth in turnover and earnings in the first half of 2023
PRESS RELEASE published on 07/29/2023 at 11:38, 1 year 3 months ago EQS-Adhoc: Leifheit Aktiengesellschaft: Resignment of the Chairman of the Board of Management
PRESS RELEASE published on 07/19/2023 at 18:43, 1 year 4 months ago EQS-Adhoc: Leifheit Aktiengesellschaft: Preliminary earnings before interest and taxes (EBIT) and preliminary free cash flow in Q2 2023 and H1 2023 significantly above previous year’s figures
PRESS RELEASE published on 06/07/2023 at 19:01, 1 year 5 months ago Leifheit Aktiengesellschaft: Annual General Meeting approves dividend and elects new member to Supervisory Board
PRESS RELEASE published on 05/11/2023 at 08:00, 1 year 6 months ago Leifheit Aktiengesellschaft: Solid start to financial year 2023
PRESS RELEASE published on 03/29/2023 at 08:05, 1 year 7 months ago Leifheit Aktiengesellschaft: Final figures for financial year 2022
PRESS RELEASE published on 03/21/2023 at 12:27, 1 year 8 months ago EQS-Adhoc: Leifheit Aktiengesellschaft: Dividend proposal, turnover and earnings forecast for financial year 2023
PRESS RELEASE published on 02/24/2023 at 08:46, 1 year 8 months ago Leifheit Aktiengesellschaft: Preliminary figures for financial year 2022
Published on 11/21/2024 at 13:30, 10 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:00, 40 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 40 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 40 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 40 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 5 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 25 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 42 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 20 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
